Molecular Autism, published by BMC in the United Kingdom, is a premier open-access journal dedicated to publishing high-quality research on the molecular and genetic factors contributing to autism spectrum disorders. Since its inception in 2010, the journal has established itself as a vital resource for researchers and clinicians, offering insights into the developmental biology, neuroscience, and psychiatric dimensions of autism. With an impressive impact factor and rankings placing it in the Q1 category across multiple relevant fields such as Developmental Biology, Developmental Neuroscience, Molecular Biology, and Psychiatry and Mental Health, it serves as a critical platform for the dissemination of innovative research and interdisciplinary collaboration. The journal encourages open dialogue through its commitment to making research freely accessible, thereby advancing knowledge and fostering advances in the understanding of autism. By bridging diverse disciplines and engaging with cutting-edge research, Molecular Autism aims to enhance our understanding of autism's complexities and inform future therapeutic approaches.

Journal of Pediatric Neurology, published by GEORG THIEME VERLAG KG, stands as a dedicated resource in the field of pediatric neurology, navigating the complex interplay of neurological and developmental disorders affecting children. With its ISSN 1304-2580 and E-ISSN 1875-9041, this journal has been a pivotal platform for advancing research since its inception in 2003, and continues to present critical findings and discussions up to 2024. Although currently categorized in the Q4 quartile for both Neurology (Clinical) and Pediatrics, Perinatology and Child Health within Scopus rankings, the journal's commitment to fostering scholarly dialogue is essential for researchers, clinicians, and students dealing with pediatric patients. Its structured coverage of various neurological disorders, treatment strategies, and innovative therapies contributes to the broader understanding of pediatric neurology, despite the challenges noted in its ranking percentile. By encouraging submissions from diverse disciplines, the journal aims to enhance clinical practice and bridge gaps in knowledge, ensuring a multidisciplinary approach to child health and development.

Neuropsychiatric Disease and Treatment, published by DOVE MEDICAL PRESS LTD, is a prominent open access journal dedicated to advancing the field of neuropsychiatry. Since its inception in 2009, this journal has provided a platform for the dissemination of high-quality research on innovative therapies and treatments for neuropsychiatric disorders. With an impressive Q2 ranking in Psychiatry and Mental Health and a Q3 ranking in Biological Psychiatry as of 2023, it holds a reputable position within the scholarly community, reflecting its commitment to impactful research. The journal's open access model ensures widespread accessibility, fostering collaboration and dialogue among researchers, clinicians, and students worldwide. The journal accepts a variety of article types, including original research, reviews, and case studies, encompassing a range of topics from pathophysiology to therapeutic advancements. With its base in New Zealand and a Scopus rank placing it within the 69th percentile of Psychiatry and Mental Health, Neuropsychiatric Disease and Treatment is an essential resource for those dedicated to understanding and treating the complexities of neuropsychiatric conditions.

Research in Autism Spectrum Disorders, an esteemed journal published by ELSEVIER SCI LTD, is dedicated to advancing the understanding of autism spectrum disorders through innovative research and scholarly articles. Since its inception in 2007, the journal has carved out a distinguished place in the field, reflected in its robust 2023 Impact Factor and Q2 ranking in key categories such as Clinical Psychology, Developmental and Educational Psychology, and Psychiatry and Mental Health. By bridging the gap between research and practice, this journal serves as a vital resource for researchers, professionals, and students alike, fostering collaboration and knowledge-sharing among those dedicated to improving outcomes for individuals with autism. Featuring a broad scope that encompasses various aspects of autism research, the journal remains committed to publishing high-quality studies that drive the conversation forward in this critical area of study. Access options for the journal's content are available under the Elsevier guidelines, ensuring that pivotal research reaches a wide audience.

BEHAVIOR MODIFICATION, published by SAGE PUBLICATIONS INC, is a prestigious journal dedicated to advancing the study and practice of behavior modification across various disciplines. With a robust ISSN of 0145-4455 and an E-ISSN of 1552-4167, this journal has established itself as a vital resource for researchers and practitioners since its inception in 1977. Recognized for its academic rigor, it is classified in the Q1 quartile for Arts and Humanities and Q2 in Clinical Psychology, as well as Developmental and Educational Psychology for 2023, showcasing its influence and relevance in these fields. The journal's Scopus rankings further exhibit its high standing, with 90th percentile in Arts and Humanities and 75th percentile in both development and clinical psychology categories. Although it is not an open-access journal, it provides essential insights and comprehensive research aimed at promoting evidence-based practices and innovative interventions in behavior modification. With a commitment to fostering interdisciplinary collaboration, BEHAVIOR MODIFICATION serves as an essential platform for researchers, professionals, and students seeking to enhance their understanding of behavioral principles to impact individual lives positively.

AUTISM, published by SAGE Publications Ltd, is a leading journal in the field of Developmental and Educational Psychology, recognized for its significant contributions to understanding autism spectrum disorders. With an impressive impact factor, AUTISM ranks in the top 94th percentile among developmental and educational psychology journals, placing it in the prestigious Q1 quartile as of 2023. Since its inception in 1997, this UK-based journal has served as a vital resource for researchers, practitioners, and students, providing a platform for high-quality empirical research, reviews, and theoretical discussions that address contemporary challenges and advancements in autism research and practice. Readers can expect to find innovative studies that influence policy, education, and treatment methodologies, making AUTISM indispensable for those dedicated to enhancing the lives of individuals on the spectrum.

Current Developmental Disorders Reports, published by SPRINGERNATURE, is a crucial resource for researchers, practitioners, and students in the fields of developmental psychology, psychiatry, and neuroscience. Since its inception in 2014, this journal has aimed to disseminate cutting-edge research on the multifaceted nature of developmental disorders, providing valuable insights into causation, diagnosis, and intervention strategies. With an E-ISSN of 2196-2987 and a notable standing in the Q3 quartile across multiple fields—developmental and educational psychology, developmental neuroscience, and psychiatry and mental health—this journal holds a significant position in the academic landscape. Researchers contributing to the journal benefit from its open access policies, stimulating knowledge sharing and dialogue within the scientific community. The journal’s commitment to advancing understanding in these critical areas of study is reflected in its rigorous publication standards and diverse range of articles, making it an essential read for anyone invested in the developments in mental health and developmental disorders.

Advances in Autism is a prominent academic journal published by Emerald Group Publishing Ltd, dedicated to the comprehensive exploration of autism spectrum disorders through the lenses of Cognitive Neuroscience, Developmental Psychology, and Psychiatry and Mental Health. Since its inception in 2015, the journal has made significant strides in disseminating high-quality research and fostering interdisciplinary collaboration within its diverse scope. With a respectable 2023 impact factor placing it in the Q3 category across multiple relevant fields, including Neurology and Clinical Psychiatry, Advances in Autism serves as an essential resource for researchers, practitioners, and students alike, aiming to advance the understanding of autism and its related challenges. Although currently not open access, the journal provides various subscription options to facilitate widespread access to its cutting-edge insights and empirical studies, making it an indispensable tool for anyone invested in autism research.

Cognitive and Behavioral Neurology is a prominent peer-reviewed journal dedicated to advancing the understanding of cognitive and behavioral aspects of neurological disorders. Published by Lippincott Williams & Wilkins, this journal has established itself as a vital resource for researchers, clinicians, and students in the fields of cognitive neuroscience, neuropsychology, and psychiatry. With an ISSN of 1543-3633 and an E-ISSN of 1543-3641, it offers a robust platform for the dissemination of high-quality research, as evidenced by its positioning in the Q3 quartiles across various categories, including Cognitive Neuroscience and Psychiatry. The journal, which has been actively publishing since 2003, encourages innovative studies that explore the intersection of cognition and behavior in neurological contexts. As a vital contributor to the academic dialogue on these topics, it provides an essential archive of findings and discussions that inform clinical practice and educational approaches, reflecting its commitment to improving patient outcomes and enhancing neurological science.

The Journal of the Korean Academy of Child and Adolescent Psychiatry (ISSN: 1225-729X; E-ISSN: 2233-9183) stands as a pivotal resource in the fields of child and adolescent mental health, contributing significantly to the dialogue on psychiatric practices and research in South Korea and beyond. Published by the KOREAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY, this journal is recognized for its dedication to advancing the understanding of psychiatric disorders that affect children and adolescents, as evidenced by its Q3 ranking in both Pediatrics, Perinatology and Child Health and Psychiatry and Mental Health categories for 2023. Operated from Seoul, South Korea, the journal facilitates knowledge-sharing among researchers and practitioners, providing insights into clinical practices and innovative treatment methodologies. Although not openly accessible, the journal emphasizes quality over quantity in its selection of studies, making each article a valuable contribution to the field. As the journal continues to publish impactful research through 2024, it remains essential reading for those committed to the well-being of younger populations and their families.